Amgen bond offering to help fund Horizon Therapeutics acquisition

Amgen bond offering to help fund Horizon Therapeutics acquisition

Source: 
Seeking Alpha
snippet: 

Amgen (NASDAQ:AMGN) has started a bond offering with the proceeds being used to help fund its planned $28B acquisition of Horizon Therapeutics (HZNP).